Skip to main content

SteelPeak Wealth, LLC

Position in CHRS — Coherus Oncology, Inc.

CIK 1801868 WOODLAND HILLS, CA

Position in CHRS

as of Jun 30, 2026 · filed Jul 13, 2026
Position Value
$96,600
-$20,010 QoQ
Shares Held
69,000
0.0% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 145 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in CHRS Over Time

Shares Held

Position Value (USD)

Derivatives in CHRS

reported options exposure · as of Dec 31, 2022
CallValue
$14,256
CallShares
1,800
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SteelPeak Wealth, LLC holds $29,382,424 across 13 Biotechnology names. CHRS ranks #12 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CHRS

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $96,600 69,000
2026-03-31 $116,610 69,000
2025-12-31 $97,980 69,000
2025-09-30 $113,160 69,000
2025-06-30 $50,439 69,000
2025-03-31 $55,683 69,000
2024-12-31 $95,220 69,000
2024-09-30 $71,760 69,000
2024-06-30 $119,370 69,000
2024-03-31 $164,910 69,000
2023-12-31 $229,770 69,000
2023-09-30 $201,960 54,000
2023-06-30 $179,340 42,000
2023-03-31 $143,640 21,000
2022-12-31 $126,720 16,000
2022-12-31 $14,256 1,800